Advances in the treatment of multiple sclerosis provide hope to thousands of sufferers in the world. In Spain alone, it affects 47,000 people and, every year, 1,800 new cases of multiple sclerosis are diagnosed, according to the Spanish Society of Neurology (SEN). Among these advances for the treatment of multiple sclerosis, the emergence of new drugs that have led to a change of approach to the disease stands out.
Medical research advances to solve many current diseases. One of them is multiple sclerosis. Until now, the causes of this disease were unknown, which meant that the options for multiple sclerosis treatment were even more limited. A recent research study, however, has discovered certain molecules that could act as immunological markers in the most severe forms of the disease. This discovery could help individualise treatments for patients at higher risk.